期刊文献+

HPLC测定银杏黄酮苷元固体分散体胶囊剂的含量 被引量:5

Determination of the Ginkgo Flavonoid Aglycon Solid Dispersions Capsules by HPLC
原文传递
导出
摘要 目的建立高效液相色谱法(HPLC)测定银杏黄酮苷元固体分散体胶囊中有效成分的含量。方法以HypersilODS(4.6mm×150mm,5μm)为色谱柱;甲醇-4‰醋酸水溶液(48:52)为流动相;流速为0.8mL·min-1,检测波长360nm,柱温45℃。结果槲皮素和山奈素5~100μg·mL-1浓度内线性关系良好,异鼠李素在3.4~68.0μg·mL-1浓度内线性关系良好,平均加样回收率分别为99.31%,99.35%和98.18%,RSD分别为2.12%,2.28%和1.65%(n=6),精密度良好。结论本方法灵敏、准确、专属性强,可作为该制剂的含量测定方法。 OBJECTIVE A HPLC method was established to determine the content of ginkgo flavonoid aglycon solid dispersions capsules.METHODS Chromatographic condition included the Hypersil ODS column(4.6 mm×150 mm,5 μm) and mobile phase consisting of methanol-4‰ acetic acid solution(48:52).The flow rate was 0.8 mL·min-1,the detection wavelength was set at 360 nm,the column temperature was 45 ℃.RESULTS The linear calibration curves were obtained in the concentration range of 5.0-100.0 μg·mL-1 and 3.40-68.0 μg·mL-1.The mean recovery was 99.31%,99.35% and 98.18%,RSD was 2.12%,2.28% and 1.65%(n=6) with good precision.CONCLUSION The method is sensitive,accurate and high selectivity.A satisfactory result to determine the dissolution of this dosage form was obtained with this method.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2010年第8期723-726,共4页 Chinese Journal of Modern Applied Pharmacy
基金 贵州省科技厅重大专项[黔科合重大专项字(2008)6020] 贵州大学2008年青年基金项目[贵大自青基合字(2007)077号]
关键词 银杏黄酮苷元固体分散体胶囊 HPLC 含量测定 Ginkgo flavonoid aglycon solid dispersions capsules HPLC content determination
  • 相关文献

参考文献9

  • 1耿秀芳,庞秀英,李桂芝.银杏叶总黄酮近期研究进展[J].中国中药杂志,2003,28(6):488-490. 被引量:48
  • 2吴超,苏红利,张晓鸣.银杏叶提取物制取黄酮苷元的酶解工艺研究[J].食品与机械,2005,21(6):27-30. 被引量:20
  • 3ONOZAWA M, FUKUDA K, OHTAN M, et al. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP [J]. Jpn J Clin Oncol, 1998, 28(6): 360-363.
  • 4AKIYAMA, ISHIDA J, NAKAGAWA S. A specific inhibitor of tyrosine protein kinases [J]. J Biol Chem, 1987, 262(12): 5592-5595.
  • 5MIKSICEK R J. Commonly occurring plant flavonoids have estrogenic activity [J]. Mol Pharmacol, 1993, 44(1): 37-43.
  • 6WEI, WEI L, FRENKEL K, et al. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein [J]. Nutr Cancer, 1993, 20(1): 1-12.
  • 7MARKOVITS, L1NASSIER C, FOSSE P, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II [J]. Cancer Res, 1989, 49(18): 5111- 5117.
  • 8POLKOWSKI K, MAZUREK A P. Biological properties of genistein [J]. Acta Plarm, 2000, 57(2): 135-155.
  • 9CLARK J W, SANTOS-MOORE A, STEVENSON L E. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the rat signaling pathway [J]. Int J Cancer, 1996, 65(2): 186-191.

二级参考文献27

  • 1耿秀芳,徐瑗民,刘同美,郭淑睿,钟桂美,李桂芝.银杏叶总黄酮的抗自由基作用[J].潍坊医学院学报,1993,15(1):10-12. 被引量:5
  • 2耿秀芳,李桂芝,王玉芬,王桂荣.银杏叶总黄酮对载脂蛋白A、B的影响[J].长春中医学院学报,1995,11(3):50-50. 被引量:2
  • 3耿秀芳.银杏叶黄酮降血脂作用的初步探讨[J].潍坊医学院学报,1992,14(1):22-22.
  • 4耿秀芳 徐爱民 郭淑睿 等.银杏叶总黄酮对SOD活力及血粘度的影响[J].山西中医,1992,8(6):42-42.
  • 5耿秀芳 张言镇 李桂芝 等.银杏叶黄酮扩血管机制的研究[J].中国中医药科技杂志,1999,6(4):238-238.
  • 6耿秀芳 李桂芝.银杏叶黄酮对ACE活性的影响[J].吉林中医药,1993,(6):37-37.
  • 7Kim S T, Effect of Biflavones of Ginlgo-biloba ,Against UVB-induced Cytotoxicity in vitro. J Dermatol, 2001 ;28(4) : 193.
  • 8Hibatallah J ,Carduner C, Poelman M C. Invivo and Invitro Assessment of the Freeredical-scavenger Activity of Ginkgo Flavons Glycosides at High concentration. J Pharm Pharmacol , 1999,51.(12): 1435.
  • 9宛志沪.银杏[M].北京:中国中医中药出版社,2001..
  • 10吴东方,周本宏,罗顺德,蔡鸿生.银杏叶总黄酮对化学性肝损伤的影响[J].中草药,1997,28(6):348-349. 被引量:39

共引文献65

同被引文献35

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部